logo
PROVIDERS
LABS
CROs
PAYORS
PATIENTS
ABOUT US
Schedule a Demo
Contact Us
Providers Psychiatry
scientists image
Overview

Elevate Mental Health Care with AI-Driven Pharmacogenomics

Personalize psychiatric treatments, minimize trial-and-error, and enhance patient outcomes across your health system.
Schedule a Demo Contact us
Overview
Psychiatric disorders often require tailored approaches due to complex patient responses to medications. PGxAI’s Psychiatry module (PGxEirene™) merges pharmacogenomics, machine learning, and real-world clinical data to streamline medication selection. By analyzing genetic markers and patient profiles, PGxAI reduces the guesswork in prescribing antidepressants, antipsychotics, and other psychiatric drugs—leading to faster therapeutic gains, fewer adverse effects, and greater patient satisfaction.
•
70+ psychiatric medications covered, from SSRIs to mood stabilizers and antipsychotics.
•
46 key genetic markers integrated to fine-tune dosage and treatment choices.
•
Real-time AI insights that adapt to each patient’s evolving needs, boosting adherence and remission rates.
Key Highlights
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
1
icon
Comprehensive Drug-Gene Analytics
Covers a broad range of antidepressants, antipsychotics, anxiolytics, and mood stabilizers, helping you select the right therapy the first time.
2
icon
Reduced Trial-and-Error
Genetic insights pinpoint optimal drug choices, minimizing the lengthy process of switching medications due to ineffective therapy or side effects.
3
icon
Enhanced Patient Engagement
Fewer adverse effects and quicker symptom relief encourage patients to stay committed to their treatment plans.
4
icon
EHR Integration
PGxEirene™ plugs seamlessly into major EHR systems, simplifying clinical workflows and delivering AI-powered recommendations within your existing platform.
5
icon
Reimbursement-Friendly
Supported by recognized CPT codes, PGxAI testing makes personalized psychiatric care both clinically effective and economically viable.
Clinical Impact
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
Faster Remission Rates
Data-driven prescribing helps patients reach therapeutic goals sooner, alleviating the burden of prolonged symptom management.
Lower Hospitalization & Readmission
Precise medication choices reduce crisis episodes and acute exacerbations, lessening the strain on inpatient resources.
Improved Provider Workflow
Psychiatrists, primary care providers, and behavioral health teams can collaborate more effectively with unified PGx insights.
Supports Value-Based Care
A reduction in emergency visits and improved mental health metrics can enhance your institution’s quality scores and financial incentives.
Drug Categories
PGxAI supports comprehensive psychiatric treatments
Schedule a Demo Contact Us
Antidepressants (SSRIs, SNRIs, TCAs):
Citalopram, Venlafaxine, Amitriptyline, etc.
Antipsychotics:
Risperidone, Quetiapine, Clozapine
Mood Stabilizers:
Lithium, Valproate, Lamotrigine
Anxiolytics & Hypnotics:
Benzodiazepines, Zolpidem, Buspirone
Substance Use Disorder Medications:
Naltrexone, Buprenorphin. Each recommendation is backed by robust AI modeling, factoring in genetic variants (e.g., CYP2C19, CYP2D6) and clinical research.
Integration
Seamless EHR Integration
PGxAI is EHR-ready and optimized for scale. Our partnership with InterSystems IRIS for Health enables real-time analysis and decision support:
icon
Security
HIPAA & SOC 2 compliance ensures patient privacy and data integrity.
icon
Automations
Automated alerts for high-risk gene-drug interactions.
icon
Analytics
Customizable dashboards for oncology pharmacists, oncologists, and care coordinators.
Case Study
Riverdale Mental Health Clinic
Schedule a Demo Contact Us
icon
Challenge
High discontinuation rates among patients on antidepressants, leading to multiple switches and frequent follow-ups.
icon
Solution
PGxAI integrated to identify optimal drug and dosage for each patient’s genetic profile.
icon
Results
35% reduction in medication switches over 6 months, higher patient satisfaction, and improved clinical outcomes.
“PGxAI has significantly reduced our trial-and-error approach. Patients are finding the right medication faster, which builds trust and stabilizes their mental health more quickly.”
human image
Dr. Emily Park
Lead Psychiatrist, Riverdale Mental Health
Whats next
Ready to Shape the Future of Precision Medicine?
Empower your psychiatry team with a data-driven solution that accelerates treatment efficacy, curbs adverse events, and keeps patients engaged.
Contact Our Psychiatry Team
Discuss pilot programs and best practices for EHR integration.
icon
Request a Demo
Discover how PGxEirene™ can be integrated into your mental health services.
icon
Learn More About EHR Integration
Explore our secure, scalable interoperability solutions.
icon